Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy is effective and well-tolerated for treating esophageal cancer.

A young woman with a rare fungal infection showed significant improvement after treatment with antifungal medication.

Certain amino acid analogues can inhibit wool and hair growth and affect fiber strength.

Kenikir leaf extract nanosuspension may help inhibit breast cancer cell growth.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Blocking autophagy increases survival of inner ear hair cells exposed to gentamicin.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Testing for the NUDT 15 variant is crucial before starting azathioprine, especially in Asians.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Eruca sativa oil, Aloe vera oil, and sodium carbonate may help improve cholesterol and tumor markers in breast cancer treatment.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Better supportive care is needed to manage chemotherapy side effects.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Nanocarriers make melatonin more effective and reduce side effects.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

Acitretin effectively improved the woman's skin condition.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.